Immune modulatory effects of ibrutinib in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Sinha, M. [1 ]
Griffith, M. [1 ]
Betts, C. [2 ]
Choe, G. [2 ]
Sivagnanam, S. [2 ]
Cheung, A. [1 ]
Tamaki, W. [1 ]
Liu, E. [1 ]
Sudduth-Klinger, J. [1 ]
Vaccaro, G. [2 ]
Lopez, C. [2 ]
Fong, L. [1 ]
Coussens, L. [3 ]
Tempero, M. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 146
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] Spatial proteomic immune profiling of pancreatic ductal adenocarcinoma and the tumor microenvironment
    Yeung, Jason
    Bai, Yunhao
    Yeo, Yao Yu
    Qiu, Huaying
    Zhu, Bokai
    Heij, Lara R.
    Abu Shah, Enas
    Nolan, Garry P.
    Sivakumar, Shivan
    Jiang, Sizun
    CANCER RESEARCH, 2024, 84 (02)
  • [22] Stromal fibrin shapes immune infiltration landscape of pancreatic ductal adenocarcinoma
    Karim, Mazharul
    Hasan, Md Mahedi
    Kim, Seung Hyun
    Azam, Zulfikar
    Wahab, Riajul
    Islam, Tamanna
    Alam, Farzana
    Kim, Yun-Jae
    Bae, Dong-Jun
    Roy, Sourav
    Grippo, Paul
    Bishehsari, Faraz
    Choi, Jeong Uk
    Al-Hilal, Taslim A.
    BIOMATERIALS, 2025, 320
  • [23] PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
    Murthy, Divya
    Attri, Kuldeep S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [24] The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma
    Wu, Zijian
    Xu, Jin
    Tang, Rong
    Wang, Wei
    Zhang, Bo
    Yu, Xianjun
    Liu, Jiang
    Shi, Si
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [25] The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma
    McIntyre, Caitlin A.
    Chakraborty, Jayasree
    Koszalka, Maura
    Bassmann, Jared
    Chou, Yuting
    Gonen, Mithat
    Allen, Peter J.
    Kingham, T. Peter
    D'Angelica, Michael I.
    Drebin, Jeffrey A.
    Jarnagin, William R.
    Do, Richard K.
    Balachandran, Vinod P.
    Simpson, Amber L.
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN
    Yamaguchi, Koji
    Kanemitsu, Shuichi
    Hatori, Takashi
    Maguchi, Hiroyuki
    Shimizu, Yasuhiro
    Tada, Minoru
    Nakagohri, Toshio
    Hanada, Keiji
    Osanai, Manabu
    Noda, Yutaka
    Nakaizumi, Akihiko
    Furukawa, Toru
    Ban, Shinichi
    Nobukawa, Bunsei
    Kato, Yo
    Tanaka, Masao
    PANCREAS, 2011, 40 (04) : 571 - 580
  • [27] Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma
    Zheng, Lei
    Xue, Jing
    Jaffee, Elizabeth M.
    Habtezion, Aida
    GASTROENTEROLOGY, 2013, 144 (06) : 1230 - 1240
  • [28] The tumor immune microenvironment is decisive in the survival of pancreatic ductal adenocarcinoma.
    Aziz, Hosein M.
    Saida, Lawlaw
    de Koning, Willem
    Stubbs, Andrew
    Li, Yunlei
    van Eijck, Casper H. J.
    Mustafa, Dana A. M.
    CANCER RESEARCH, 2021, 81 (22) : 80 - 81
  • [29] Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes
    Liu, Rong
    Liao, Ya-Zhou
    Zhang, Wei
    Zhou, Hong-Hao
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [30] Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
    Akhuba, Liia
    Tigai, Zhanna
    Shek, Dmitrii
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 327 - 331
12345